Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
October 14th, 2021 |
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 14th, 2021 |
Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed) |
National Institutes of Health |
August 20th, 2021 |
Launching Future Leaders in Global Health (LAUNCH) Research Training Program (D43 Clinical Trial Optional) |
National Institutes of Health |
July 19th, 2021 |
Service Area Competition |
Health Resources and Services Administration |
July 19th, 2021 |
Service Area Competition |
Health Resources and Services Administration |
July 19th, 2021 |
Delta Healthcare Services Grant |
Rural Business Cooperative Service |
June 9th, 2021 |
Local Community-Based Workforce to Increase COVID-19 Vaccine Access |
Health Resources and Services Administration |
May 7th, 2024 |
NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
August 20th, 2021 |
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) |
National Institutes of Health |
June 10th, 2021 |
USAID Social and Behavior Change (SBC) MALARIA Program in Mozambique |
Mozambique USAID Maputo |
May 7th, 2024 |
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required) |
National Institutes of Health |
October 7th, 2022 |
Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical |
National Institutes of Health |
July 20th, 2021 |
Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India |
Centers for Disease Control CGH |
July 16th, 2021 |
Optimizing Virtual Care (OVC) |
Health Resources and Services Administration |
July 12th, 2021 |
Service Area Competition |
Health Resources and Services Administration |
June 14th, 2021 |
Community Led Monitoring Activity in the Kyrgyz Republic |
Kazakhstan USAID Almaty |
February 28th, 2024 |
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) |
National Institutes of Health |
July 30th, 2021 |
Pediatric Environmental Health Specialty Unit (PEHSU): Expansion Supplement |
Centers for Disease Control ATSDR |
July 10th, 2021 |
Strengthening detection, prevention and response to infectious disease threats in Uzbekistan |
Centers for Disease Control CGH |
|
September 3rd, 2021 |
Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 30th, 2021 |
SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) |
National Institutes of Health |
July 9th, 2021 |
Strengthening detection, prevention and response to infectious disease threats in Kazakhstan |
Centers for Disease Control CGH |
May 7th, 2024 |
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2024 |
Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) |
National Institutes of Health |
May 7th, 2024 |
NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
October 20th, 2021 |
Standardization of C-Peptide and HbA1C Measurements Program (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 20th, 2024 |
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2022 |
NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required) |
National Institutes of Health |
April 19th, 2022 |
Enhancing National STD/HIV Prevention Efforts by Promoting Holistic, Comprehensive and Evidence-Informed, Health and Wellness Approaches through Strategic Partnerships |
Centers for Disease Control NCHHSTP |
September 7th, 2024 |
NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
February 20th, 2024 |
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
August 4th, 2021 |
Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed) |
National Institutes of Health |
June 28th, 2021 |
Enhancing Water, Sanitation and Hygiene (WASH) Activity |
Ghana USAID Accra |
June 7th, 2021 |
Guinea Local Health System Strengthening Activity (LHSSA) |
Guinea USAID Conakry |
October 7th, 2022 |
Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 |
National Institutes of Health |
July 6th, 2021 |
Technical Collaboration to Strengthen Bangkok Metropolitan Administration Capacity to Detect, Prevent, Respond, Monitor, and Mitigate The Effects of Public Health Threats In The Kingdom of Thailand. |
Centers for Disease Control CGH |
May 7th, 2025 |
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed) |
National Institutes of Health |